Company / AR per Share
Idexx Laboratories AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$6.77
FY2025
5-year range
$4.31 / $6.77
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
#34 of 141
Health Care
What the data says
Idexx Laboratories's ar per share of $6.77 is higher than 76% of companies in the Health Care sector (FY2025). AR per Share has increased for 9 consecutive years, from $2.01 in FY2016 to $6.77 in FY2025.
Based on SEC 10-K filings.
6.77 in FY2025 with a 5-year CAGR of +11.8%. Top quartile in the Health Care sector.
Improved from $5.52 to $6.77 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +11.8%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 141This company $6.77 Sector average $11.78
▼
-42.5% below sector average
Key checks
Key Insights
- Idexx Laboratories's ar per share has grown for 9 consecutive years.
- In FY2025, ar per share increased 18.7% year-over-year.
- Ranks #34 out of 141 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.77 | +18.7% |
| FY2024 | $5.70 | +3.4% |
| FY2023 | $5.52 | +16.5% |
| FY2022 | $4.74 | +9.9% |
| FY2021 | $4.31 | +11.2% |
| FY2020 | $3.88 | +24.0% |
| FY2019 | $3.13 | +9.5% |
| FY2018 | $2.86 | +14.0% |
| FY2017 | $2.51 | +24.3% |
| FY2016 | $2.01 | +15.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026